Other than anticoagulation, what is the best therapy for those with atrial fibrillation?
Abstract
Rate control with long-term anticoagulation is recommended for most patients with atrial fibrillation (strength of recommendation [SOR]: A, based on randomized controlled trials [RCTs]). A rhythm-control strategy provides no survival or quality-of life benefit when compared with rate control and causes more adverse drug effects and increased hospitalizations (SOR: A, based on RCTs).
Rights
OpenAccess.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.